RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing acute care therapeutic drug products for infectious diseases and cardiovascular disorders, will host a webcast event on Heparin, Bleeding Complications, and PolyMedix’s PMX-60056 Heparin Reversing Agent on Tuesday, December 15, 2009 at 10:00 am EST.
